We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
-16.73%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$300M
AUM Growth
-$39.4M
Cap. Flow
+$19.1M
Cap. Flow %
6.37%
Top 10 Hldgs %
40.88%
Holding
110
New
17
Increased
29
Reduced
31
Closed
33

Top Buys

Rank Stock Value
1
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$15.1M
2
AET
Aetna Inc
AET
+$9.05M
3
LAB icon
Standard BioTools
LAB
+$7.23M
4
SPNC
Spectranetics Corp
SPNC
+$6.43M
5
STJ
St Jude Medical
STJ
+$5.86M

Top Sells

Rank Stock Value
1
LH icon
Labcorp
LH
+$9.99M
2
BCR
CR Bard Inc.
BCR
+$9.92M
3
ELV icon
Elevance Health
ELV
+$6.68M
4
WBA
Walgreens Boots Alliance
WBA
+$6.22M
5
ISRG icon
Intuitive Surgical
ISRG
+$4.21M

Sector Composition

Rank Sector Weight
1 Healthcare 88.86%
2 Financials 3.68%
3 Industrials 1.11%
4 Technology 1.01%
5 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VIRX
76
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$156K 0.05%
919
-454
-33% -$164K
BDSI
77
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$131K 0.04%
23,500
-269,600
-92% -$1.99M
ALGN icon
78
Align Technology
ALGN
$12.3B
– –
-10,700
Closed -$671K
BAX icon
79
Baxter International
BAX
$14.5B
– –
-95,916
Closed -$3.64M
BLUE
80
DELISTED
bluebird bio
BLUE
– –
-270
Closed -$589K
CLDX icon
81
Celldex Therapeutics
CLDX
$2.98B
– –
-1,240
Closed -$469K
CVS icon
82
CVS Health
CVS
$134B
– –
-11,700
Closed -$1.23M
DHR icon
83
Danaher
DHR
$139B
– –
-30,575
Closed -$1.76M
ELV icon
84
Elevance Health
ELV
$82.3B
– –
-40,675
Closed -$6.68M
ILMN icon
85
Illumina
ILMN
$30.2B
– –
-6,419
Closed -$1.36M
ISRG icon
86
Intuitive Surgical
ISRG
$134B
– –
-78,300
Closed -$4.21M
NBIX icon
87
Neurocrine Biosciences
NBIX
$16.9B
– –
-14,900
Closed -$712K
NVS icon
88
Novartis
NVS
$291B
– –
-47,095
Closed -$4.15M
PBYI icon
89
Puma Biotechnology
PBYI
$383M
– –
-3,700
Closed -$432K
PODD icon
90
Insulet
PODD
$11.8B
– –
-14,150
Closed -$438K
STRM
91
DELISTED
Streamline Health Solutions
STRM
– –
-13,309
Closed -$559K
TFX icon
92
Teleflex
TFX
$6.23B
– –
-11,900
Closed -$1.61M
UHT
93
Universal Health Realty Income Trust
UHT
$594M
– –
-18,300
Closed -$850K
WBA
94
DELISTED
Walgreens Boots Alliance
WBA
– –
-73,700
Closed -$6.22M
CTLT
95
DELISTED
CATALENT, INC.
CTLT
– –
-23,100
Closed -$678K
NSTG
96
DELISTED
NanoString Technologies, Inc.
NSTG
– –
-175,961
Closed -$2.71M
ACOR
97
DELISTED
Acorda Therapeutics
ACOR
– –
-80
Closed -$320K
XENT
98
DELISTED
Intersect ENT, Inc
XENT
– –
-17,135
Closed -$491K
GNMK
99
DELISTED
GenMark Diagnostics, Inc
GNMK
– –
-59,070
Closed -$535K
VAR
100
DELISTED
Varian Medical Systems, Inc.
VAR
– –
-4,949
Closed -$366K
1 2 3
4
5

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q3 2015 Portfolio in Review

As of Q3 2015, Endurant Capital Management held 110 positions worth $300M, down 12% from $339M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Endurant Capital Management deployed $19.1M of net new capital in Q3 2015, opening 17 new positions and adding to 29 existing holdings. Its largest new stake was AMAG Pharmaceuticals: 94,100 shares worth $3.74M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, down from 90% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Labcorp, an estimated $9.99M trimmed.

  • Endurant Capital Management's largest Q3 2015 buy was AMAG Pharmaceuticals: 94,100 shares worth $3.74M.
  • Endurant Capital Management added most to MALLINCKRODT PUBLIC LIMITED COMPANY in Q3 2015, an estimated $15.1M increase.
  • Endurant Capital Management's biggest Q3 2015 reduction was Labcorp, cutting an estimated $9.99M.
  • Endurant Capital Management fully exited Elevance Health in Q3 2015, selling an estimated $6.68M.
  • Endurant Capital Management's ten largest holdings make up 41% of its $300M portfolio in Q3 2015.
  • Endurant Capital Management opened 17 new positions and closed 33 in Q3 2015.
  • Endurant Capital Management's portfolio value fell 12% quarter-over-quarter to $300M.

Based on Endurant Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.